ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,840Medicare Part D Prescriptions Filled, Including Refills

Rank: 60 out of 617

$507K Total Retail Price of All Prescriptions

Rank: 95 out of 617

419 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 419 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

17% of this provider’s 419 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 10,441 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
LEVOTHYROXINE SODIUM 765 695 1 1
OMEPRAZOLE 516 452 2 3
SIMVASTATIN 425 414 3 2
LISINOPRIL 333 290 4 5
FUROSEMIDE 318 284 5 4
METOPROLOL TARTRATE 302 291 6 11
AMLODIPINE BESYLATE 296 284 7 6
METFORMIN HCL 293 258 8 9
WARFARIN SODIUM 290 248 9 7
POTASSIUM CHLORIDE 272 225 10 10
HYDROCODONE-ACETAMINOPHEN 256 201 S3 11 8
MELOXICAM 206 196 12 24
LOSARTAN POTASSIUM 186 184 13 22
TRAMADOL HCL 185 177 14 15
HYDROCHLOROTHIAZIDE 172 160 15 13
GABAPENTIN 169 148 16 16
ATENOLOL 161 161 17 17
ATORVASTATIN CALCIUM 152 135 18 14
SERTRALINE HCL 141 123 19 20
TAMSULOSIN HCL 133 110 20 26
LISINOPRIL-HYDROCHLOROTHIAZIDE 129 125 21 29
ALENDRONATE SODIUM 121 121 22 25
METOPROLOL SUCCINATE 116 116 23 12
ESCITALOPRAM OXALATE 108 99 24 65
RANITIDINE HCL 105 79 25 40
CRESTOR 102 90 26 28
GLIPIZIDE ER 98 82 27 94
ENALAPRIL MALEATE 96 89 28 34
PREDNISONE 96 95 28 31
BISOPROLOL FUMARATE 94 79 30 100
ALLOPURINOL 92 87 31 27
PANTOPRAZOLE SODIUM 90 78 32 37
CARVEDILOL 89 89 33 19
DOXAZOSIN MESYLATE 88 88 34 79
DETROL LA 88 75 34 127
TRIAMTERENE-HCTZ 86 86 36 47
NAMENDA 85 85 37 35
ZOLPIDEM TARTRATE 83 81 38 23
POLYETHYLENE GLYCOL 3350 82 68 39 32
CARBIDOPA-LEVODOPA 81 77 40 69
FLUTICASONE PROPIONATE 76 61 41 36
CITALOPRAM HBR 72 43 42 18
DIGOXIN 72 65 42 48
CLOPIDOGREL 72 67 42 53
AZITHROMYCIN 70 61 45 70
OXYBUTYNIN CHLORIDE 69 68 46 88
MIRTAZAPINE 68 55 47 50
ZETIA 68 68 47 77
DONEPEZIL HCL 67 67 49 30
FENOFIBRATE 66 66 50 58
FENTANYL 66 38 S2 50 45
EXELON 63 63 52 156
LOVASTATIN 61 48 53 57
PLAVIX 59 54 54 86
LANTUS 57 56 55 39
CLONIDINE HCL 55 47 56 55
CYCLOBENZAPRINE HCL 54 37 R 57 74
DILTIAZEM 24HR ER 53 32 58 162
DILTIAZEM 24HR CD 53 48 58 117
TRICOR 52 52 60 83
CIPROFLOXACIN HCL 52 48 60 60
MECLIZINE HCL 51 49 62 150
NEXIUM 51 51 62 43
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 6, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.